Biotech Stocks and Advisory Committees: No News Is Good News?
This article was originally published in RPM Report
Executive Summary
FDA has approved six new molecules already in 2012--and five were approved without going to an advisory committee. Meanwhile, FDA has held four advisory committees to review new drug applications, and all four ended in overwhelming "no" votes.